Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.

In conclusion, ERCC1 rs11615, rs2298881 and ERCC2 rs1799793 polymorphism play an important role in the treatment outcome of gastric cancer. PMID: 26097599 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26097599?dopt=Abstract

Source: International Journal of Clinical and Experimental Pathology - June 26, 2015 Category: Pathology Authors: Yu H, Wu X, Zhang Y, Jin Z, Li G, Zhao H Tags: Int J Clin Exp Pathol Source Type: research